Q1 EPS Estimates for Henry Schein Reduced by Leerink Partnrs

Henry Schein, Inc. (NASDAQ:HSIC) – Analysts at Leerink Partnrs cut their Q1 2025 earnings estimates for Henry Schein in a research report issued on Tuesday, February 25th. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings of $1.14 per share for the quarter, down from their prior estimate of $1.19. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein’s Q3 2025 earnings at $1.26 EPS.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The firm had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the previous year, the firm posted $0.66 earnings per share.

Several other analysts have also recently issued reports on HSIC. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and upped their price target for the company from $69.00 to $84.00 in a report on Monday, January 6th. Jefferies Financial Group upped their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. UBS Group dropped their target price on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday. Finally, Mizuho started coverage on shares of Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price on the stock. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, Henry Schein presently has an average rating of “Moderate Buy” and an average price target of $81.10.

Henry Schein Trading Up 0.1 %

HSIC opened at $72.17 on Friday. The stock has a market capitalization of $9.00 billion, a PE ratio of 29.70, a P/E/G ratio of 2.13 and a beta of 0.91. The firm’s fifty day moving average price is $74.35 and its 200 day moving average price is $72.42. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein has a 12-month low of $63.67 and a 12-month high of $82.49.

Hedge Funds Weigh In On Henry Schein

Several institutional investors have recently modified their holdings of HSIC. Palestra Capital Management LLC bought a new position in shares of Henry Schein during the fourth quarter worth about $182,988,000. Lyrical Asset Management LP bought a new position in Henry Schein in the 4th quarter valued at about $126,655,000. Norges Bank bought a new position in Henry Schein in the 4th quarter valued at about $103,301,000. Steadfast Capital Management LP grew its position in Henry Schein by 254.2% in the 4th quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company’s stock valued at $113,336,000 after buying an additional 1,175,408 shares in the last quarter. Finally, ING Groep NV bought a new position in Henry Schein in the 3rd quarter valued at about $63,226,000. Institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.